Quest Diagnostics, LabCorp price targets raised at Citigroup

theflyonthewall.com

Citigroup raised its price target for Quest Diagnostics (DGX) to $60 from $58 and for LabCorp (LH) to $106 from $94 after a House bill delayed reimbursement cuts. Citi thinks the recent rally in both stocks reflects the news, however, and keeps a Neutral rating on both names.

View Comments (1)